Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance

Indofarma Tbk.Trade
Zyrexindo Mandiri Buana Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Zyrexindo Mandiri Buana Tbk. trades at Rp127 (market cap 172B, 315.2K 24h volume). The key difference: Indofarma Tbk. is far larger — about 2.3× Zyrexindo Mandiri Buana Tbk.'s market cap. Which is the better fit depends on your goals.

INAFZYRX
Market Cap
390.51B172B
Volume
315.2K
Lot
3.15K
Turnover
40.04M
Average Price
127.02
Value
40.04M
Indicative Equilibrium Price
127
Indicative Equilibrium Volume
400

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
ZYRX
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Zyrexindo Mandiri Buana Tbk.

PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik

Read more on ZYRX